AGM format and COVID-19

Arrangements for the 2021 Annual General Meeting (‘AGM’) in light of Coronavirus (COVID-19)

Whilst our preference would have been to welcome shareholders in person at our 2021 AGM, at the publication date of our Notice of Meeting, UK legislation and government guidance relating to COVID-19 prohibits indoor public gatherings. Therefore, our 2021 AGM will be convened with the minimum quorum of shareholders present in order to conduct the business of the meeting and it will not be possible for you to attend the AGM in person. Accordingly, you should appoint the Chairman of the meeting as your proxy as any other proxy will not be permitted to attend the meeting.

Where possible, we would like to encourage you to submit your vote electronically through CREST.  However, if you do require a copy of the proxy form this can be downloaded here. Once printed, please complete your proxy form in the usual way in accordance with the instructions thereon, ensuring your full name, post code and shareholder reference number if known is included.  Once completed and signed, please scan or take a picture of your proxy form and e-mail it to proxyvotes@equiniti.com. We strongly encourage you to exercise your right to vote and to submit your proxy form as early as possible. In order to be valid proxy forms must be received by Equiniti no later than 11.00am on Tuesday 4 May 2021.

Please remember that if you are the beneficial owner of shares who has been nominated by a registered holder to enjoy information rights, in order to vote you must contact the registered holder of the shares i.e. the nominee or custodian who looks after your shares on your behalf.

The Board of Directors recognise that the AGM is an important event which provides our shareholders with the opportunity to meet and ask questions to the Board of Directors. As the current situation means face to face contact cannot take place, should you have any specific questions on the business of the AGM and resolutions please submit these ahead of the meeting by e-mail to investor.relations@genelenergy.com. We will endeavour to publish these questions and answers on our website after the meeting.

For up to date information and advice on Coronavirus please visit www.nhs.uk/coronavirus

Date this page was last updated: 1 April 2021